International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Page(s): 444

PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, North American Menopause Society, bioidentical hormone replacement therapy, bHRT, unapproved drugs, U.S. Food and Drug Administration, FDA

Related Categories: HRT, LEGAL, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement Allen Loyd V Jr	Nov/Dec 2017 Pg. 444
The Science Behind Hormone Replacement Therapy, Part 1 Wepfer Scott T	Nov/Dec 2001 Pg. 462-464
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Bioidentical Hormone Replacement Therapy, Part 3, A Review of Wepfer Scott T	Mar/Apr 2002 Pg. 142-146
Gender Bias in the Treatment of Menopausal Women: I am Hot as Hell and Not Going to Take It Anymore, Part 1 DeRosa Angela	Nov/Dec 2020 Pg. 466-470
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Stephenson Kenna, Jones William, Stephenson Douglas M M	May/Jun 2006 Pg. 175-183
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Gillson George R, Zava David T	Jul/Aug 2003 Pg. 250-256
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Deleruyelle Laura J	Sep/Oct 2016 Pg. 359-364
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment Lorentzen Jean	Sep/Oct 2001 Pg. 336-338
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens-Part 1 Ford Gina, Garcia Lea	Nov/Dec 2000 Pg. 421-422
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J	Jul/Aug 2004 Pg. 313-319
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Ford Gina, Garcia Lea	Jan/Feb 2001 Pg. 52-54
Bioidentical Hormone Replacement Therapy, Part 2, A Review of Wepfer Scott T	Jan/Feb 2002 Pg. 50-54
The Politics of Hormone Replacement Therapy Allen Loyd V Jr	Jul/Aug 2007 Pg. 278-281
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Deleruyelle Laura J	Nov/Dec 2016 Pg. 447-454
Natural Progesterone in Natural Hormone Replacement Therapy, The Role of Girouard Lorinda G, Holm Richard C	May/Jun 2001 Pg. 218-220
Hormone Therapy: It's Time for a Second Opinion Collins Joseph J, Ahlgrimm Maria	Mar/Apr 2008 Pg. 122-127
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study Moro Doris, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah	Mar/Apr 2010 Pg. 165-170
The U.S. Food and Drug Administration Takes Aim at Compounded Thyroid Hormone Brunner Scott	Jan/Feb 2023 Pg. 22-23
Return to Top